Skip Navigation LinksHome > July 2014 - Volume 25 - Issue 4 > Smoking and Risk of Multiple Sclerosis: Evidence of Modifica...
doi: 10.1097/EDE.0000000000000089
Neurologic Disease

Smoking and Risk of Multiple Sclerosis: Evidence of Modification by NAT1 Variants

Briggs, Farren B. S.a; Acuna, Brigidb; Shen, Lingb; Ramsay, Patriciaa; Quach, Honga; Bernstein, Allanc; Bellesis, Kalliope H.b; Kockum, Ingrid S.d; Hedström, Anna K.e; Alfredsson, Larse; Olsson, Tomasd; Schaefer, Catherineb,*; Barcellos, Lisa F.a,b,*

Supplemental Author Material
Collapse Box


Background: Tobacco smoke is an established risk factor for multiple sclerosis (MS). We hypothesized that variation in genes involved in metabolism of tobacco smoke constituents may modify MS risk in smokers.

Methods: A three-stage gene-environment investigation was conducted for NAT1, NAT2, and GSTP1 variants. The discovery analysis was conducted among 1588 white MS cases and controls from the Kaiser Permanente Northern California Region HealthPlan (Kaiser). The replication analysis was carried out in 988 white MS cases and controls from Sweden.

Results: Tobacco smoke exposure at the age of 20 years was associated with greater MS risk in both data sets (in Kaiser, odds ratio [OR] = 1.51 [95% confidence interval (CI) = 1.17–1.93]; in Sweden, OR = 1.35 [1.04–1.74]). A total of 42 NAT1 variants showed evidence for interaction with tobacco smoke exposure (Pcorrected < 0.05). Genotypes for 41 NAT1 single nucleotide polymorphisms (SNPs) were studied in the replication data set. A variant (rs7388368C>A) within a dense transcription factor-binding region showed evidence for interaction (Kaiser, OR for interaction = 1.75 [95% CI = 1.19–2.56]; Sweden, OR = 1.62 [1.05–2.49]). Tobacco smoke exposure was associated with MS risk among rs7388368A carriers only; homozygote individuals had the highest risk (A/A, OR = 5.17 [95% CI = 2.17–12.33]).

Conclusions: We conducted a three-stage analysis using two population-based case-control datasets that consisted of a discovery population, a replication population, and a pooled analysis. NAT1 emerged as a genetic effect modifier of tobacco smoke exposure in MS susceptibility.

© 2014 by Lippincott Williams & Wilkins, Inc

Twitter  Facebook 


Article Tools


Article Level Metrics